Tuesday, December 08, 2015

Wall Street Traders Doubt Legacy Reserves' Survival

›
The markets continue to signal that energy MLP Legacy Reserves (LGCY - $1.76) is on the brink – of a potential bankruptcy filing: the pr...
Saturday, November 14, 2015

How Radical Islam Is Destroying the West

›
"In the end, Europe's enemy is not Islam, or even radical Islam. Europe's enemy is itself—its self-destructive passivity, its...
1 comment:
Thursday, September 17, 2015

More Lies from Magnum Hunter Resources?

›
The price of Magnum Hunter Resources (MHR - $0.52) soared more than 70% to $1.33 per share on August 10 when the Marcellus/Utica NG drille...
1 comment:
Saturday, September 12, 2015

Does Magnum Hunter Resources Have a Winning Bid - or Not?

›
Management of   Magnum Hunter Resources ($0.67)   said on the August 5 earnings call that a decision on the Eureka Hunter pipeline asset...
Monday, August 17, 2015

Looking at Southcross Energy's 21% Yield? Don't

›
At  $7.50, the share price of Southcross Energy Partners (SXE) offers a 21.3% dividend yield. Income investors who have stopped to sniff...
1 comment:
Friday, May 01, 2015

Looking for Value? Start with Truth-Telling at EXCO Resources

›
Wow! How refreshing to witness a senior executive immune to the “Bullsh-t Syndrome” (the commonplace corporate condition where imaginary ...
1 comment:
Tuesday, March 31, 2015

Oil Glut Doesnt Mean U.S. Running Out of Crude Storage Capacity

›
Although the U.S. rig count has fallen dramatically, reaching the lowest level since April 2011, domestic crude output continues to soar...
1 comment:
Tuesday, March 17, 2015

Linn Energy's Price Decline to Accelerate

›
Attracted to Linn Energy’s (LINE-$10.93) turnaround potential (share price is off 62.5% from its 52-week high) and 11.2% payout ($1.25 d...
Friday, February 20, 2015

EU Kicks Can on Greek Debt Down the Road -- Again

›
Eurozone finance ministers demonstrated their continued lack of resolve by kicking the can down the road – again: an agreement has been r...
Wednesday, February 18, 2015

Is Janet Yellen Too Chummy With Wall Street?

›
Is this bull market too dependent on "easy money" policies - QE? Could it be that the real reason that Fed Chairwoman Janet Y...
1 comment:
Friday, February 06, 2015

Is Carly Fiorina Accomplished Enough for a White House Run?

›
Former Hewlett-Packard (HPQ-$$37.95) CEO Carly Fiorina criticized preordained 2016 Democratic presidential contender Hillary Clinton ...
Tuesday, February 03, 2015

Energy Stocks Surge on Expected Bottoming in Crude Prices

›
Nordic American Offshore (NAO-$11.11) management has repeatedly stated that the fundamentals of its PSV (platform supply vessel) leasing...
Monday, February 02, 2015

Finding Opportunity in Crude Oil's Bust - Part 3

›
Natural Resource Partners LP (NRP-$9.39) is principally engaged in the business of owning and managing mineral reserve properties.  NRP ...

Finding Opportunity in Crude Oil's Bust - Part 2

›
Evolution Petroleum Corp. (EPM-$7.51) is an E&P specializing in lower cost secondary recovery efforts. Debt-Free Balance Sheet 2...
Sunday, February 01, 2015

Finding Opportunity in Crude Oil's Bust - Part 1

›
Though the Energy Information Administration (EIA) expects global oil inventories to continue to build in 2015, the downward pressure on ...
Wednesday, January 14, 2015

Calling Saudi Arabia's Oil Bluff

›
Saudi Oil Minister Ali al-Naimi keeps telling us that the world's top petroleum exporter is not going to cut production to prop up g...
2 comments:
Thursday, October 09, 2014

Price Transparency Benefits Hospital Patients

›
Internet access has ushered in an era of price transparency, where shoppers wielding smartphones check prices before deciding where to bu...
Monday, September 29, 2014

Watching Television for Allergy Relief

›
Looking to master the quiet sneeze or get relief from those itchy, watery eyes? If so, consider watching television, at least long enou...
Friday, September 26, 2014

Can Conatus Pharmaceuticals Duplicate Intercept's Success?

›
Conatus Pharmaceuticals (CNAT-$6.03) is developing a first-in-class, orally active pan-caspase protease inhibitor, called emricasan, which...
Monday, September 08, 2014

Keryx Biopharmaceutical's Kidney Drug Approved - What Now?

›
Keryx Biopharmaceuticals, Inc.   (KERX-$17.01) announced that the FDA approved Ferric Citrate (formerly known as Zerenex) for the contr...